PushCART Therapeutics, Inc.
PrivateLast Round
Seed
Jul 31, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PushCART Therapeutics, Inc. is a biotechnology company that develops cell therapies designed to treat solid tumors by enabling immune cells to penetrate dense fibrosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PushCART Therapeutics, Inc. Comparables
Compare PushCART Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inceptor Bio | 80% | |
| Innovative Cellular Therapeutics | 77% | |
| Dispatch Biotherapeutics | 76% |
PushCART Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 31, 2026 | ||||
| Seed | Apr 27, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 31, 2026
$500K Seed Round raised.
- Apr 27, 2026
Completed a Seed funding round.
PushCART Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PushCART Therapeutics, Inc.'s valuation, stock price, and market status.
Is PushCART Therapeutics, Inc. a public or private company?
PushCART Therapeutics, Inc. is a private company.
What is the current stock price of PushCART Therapeutics, Inc.?
PushCART Therapeutics, Inc. is a private company with no public stock price. Caplight tracks PushCART Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is PushCART Therapeutics, Inc. worth (valuation)?
Valuation information for PushCART Therapeutics, Inc. is not publicly available.
Can I buy PushCART Therapeutics, Inc. stock?
PushCART Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was PushCART Therapeutics, Inc.'s last funding round?
PushCART Therapeutics, Inc.'s most recent funding round was Seed Round on July 31, 2026.
Who are the main investors in PushCART Therapeutics, Inc.?
Investor information for PushCART Therapeutics, Inc. is not publicly disclosed.
Will PushCART Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for PushCART Therapeutics, Inc..
How can I track PushCART Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PushCART Therapeutics, Inc.'s secondary market activity and sign up for updates.